MediciNova, Inc. (MNOV) Social Stream



MediciNova, Inc. (MNOV): $1.78

0.19 (-9.62%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

Add MNOV to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#185 of 402

in industry

MEDICINOVA INC (MNOV) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering MNOV.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-30 3 $27 $10 $16.5 $1.53 978.43%
2022-03-01 3 $27 $6 $14.333 $1.53 836.8%
2022-04-06 1 $27 $6 $14.333 $1.53 836.8%
2022-08-19 2 $27 $6 $13 $1.53 749.67%
2023-02-27 3 $27 $6 $13 $1.53 749.67%
2023-05-30 2 $27 $6 $16.5 $1.53 978.43%
2023-08-21 1 $26 $6 $16 $1.53 945.75%
2023-11-27 1 $27 $6 $16.5 $1.53 978.43%

Price Target Last Issued August 21, 2023

The Trend in the Analyst Price Target


Over the past 24 months, MNOV's average price target has gone up $10.5.

Over the past 39 weeks, MNOV's average upside potential has been 703%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-27 2 27 6 16.5 2.21 646.61%
2023-02-27 2 27 6 13.0 2.21 488.24%
2023-05-30 2 27 6 16.5 2.14 671.03%
2023-08-21 2 26 6 16.0 2.36 577.97%
2023-11-27 1 27 27 27.0 1.78 1416.85%

MNOV Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


Over the past 36 months, MNOV's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, MEDICINOVA INC's upside potential (average analyst target price relative to current price) is greater than 1260.07% of them.
  • In terms of how MEDICINOVA INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 40.84% of that group.
  • To contextualize these metrics, consider that out of all US stocks, MEDICINOVA INC's variance in analysts' estimates is lower than -1031.37% of them.
  • MNOV has a higher average analyst price target than 363.84% of Healthcare stocks.

In the Pharmaceutical Products industry, SVRA, BPTH, and ONTX are the three stocks most similar to MEDICINOVA INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding MNOV using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!